Module 2- Respiratory Flashcards
Cough
most common symptom for which patients seek attention, adversely affects person and work interaction, sleep and causes discomfort
Cough Symptoms
Acute-less than 3 weeks,
persistent- 3-8 weeks
Chronic- >8 weeks
Post-infection cough lasting 3-8 weeks also called a subacute cough
Acute Cough
due to VRI- fever, nasal congestion and sore throat help dx
Dyspnea- more serious disease,
Prominent natural cough= Asthma
persistent with phlegm= CPOD
posttussive emesis/inspiratory whoop= pertussis
Persistent and chronic Cough
Pertussis should be considered in adults/teens with severe cough more than 3 weeks
ACE inhibitors
Asthma, GERD, postnasal drip,
dyspnea not likely
Excessive mucous with chronic cough = COPD
Dry eyes with chronic cough= Sjogren Syndrome
Chronic dry may be idiopathic pulmonary fibrosis
Physical Exam for Cough
Vital sign abn? (fever, tachy, tachypnea- PNA)
airspace consolidation? (crackles, decreased, - CPNA)
Purulent Sputum- Bacterial infections in structural lung disease
Wheezing/Rhonchi- bronchitis
Chronic cough- COPD vs HF vs sinusitis
Treatment for acute cough
Target underlying issue
Flu- oseltamivir/sanamivir
Mycoplasma/Chlamydophlia-erythomycin/zithromax
bronchitis w/ wheezing- inhaled agonist therapy
Persistent and Chronic Cough tx
evaluation and management require multiple visits and trials
Pertusis- Macrolide abx early, tx does not help the cough if tx pass 7-10 of onset
Empiric therapy for nasal drip, asthma, GERD
When empiric fails- consider other causes
When to refer with cough
Failure to control cough following empiric tx trials
recurrent symptoms
When to admit with cough
High risk TB with noncompliance with precautions
Urgent bronch due to foreign body
smoke/toxic inhalational injury
gas exchange impaired by cough
high risk for barotrauma- pneumothorax
Community-acquired pneumonia- CAP Risk Factors
advanced age, alcoholism, tobacco, comorbid medical conditions (asthma/COPD), immunosuppression
CAP definition
Occurs when a defect in pulmonary defense system- cough reflex, mycocilary clearance system, immune response- or when a large infectious incoculum or a virulent pathogen overwhelms immune response
INFECTED Parenchyma
CAP Pathogenesis
30-60% of cases fail to identify cause
Bacterial: S. Pneumoniae, H. Flu, M Pneumoniae, C, pneumoniae, S aureus, Klebsiella, Legionella
Viruses- Corona, Flu, adenovirus, parainfluenza, respiratory syncytial
Signs and Symptoms of CAP
Acute/subacute fever, cough w or w/out sputum, dyspnea, Chest pain, Headache, fatigue,
Common physical findings: hypothermia, tachypnea, tachy, desaturation, crackles, bronchial breath sounds, dullness to percussion, AMS- esp with elderly
Diagnostic testing- CAP
Typically not required for ambulatory patients, empirical treatment almost always works
Xray is Gold standard
Lab work- WBC
leukocytosis
COVID/FLU
Sputum gram stain
Urinary antigen test s. pneumonia and legionella species
Treatment of Viral CAP
start within 48 hours of illness
*oesltamtivir 75mg x5 days
*Baloxavir 40-79 kg 40 mg x1 and >80kg 80mg x1
*IV Peramivir 600mg x1
*Zanamivir 10mg 2 inh BID x5 days- (don’t use with asthma=bronchospasm)
Outpatient management of Bacterial CAP
Healthy with no risk factors for MRSA/pseudomonas
*amoxicillin- 1g TID
*doxy 100mg BID x 5 days
*Macrolidies- Zithromax- 500mg x1 day then 250mg/x4 days
Clarthromycin 500mg BID x 5 days
Cormorbid medical conditions
*Macrolide or doxy plus oral beta-lactam
*mono-therapy with fluoroquinolone
*Moxifloxacin 400mg/d, Gemifloxacin 320mg/day, levofaxacin 750mg/d
Indications of Hospitalization for CAP
Severe illness- Resp compromised
inability to take oral fluids
poor compliance with medications
Substance abuse
cognitive impairment- Always
poor living situation or social support
inadequate finical resources
Prevention of CAP
Vaccine- Pneumovax 23 & Prevanr-13
Flu vaccine
Covid Vaccine
Anaerobic Pneumonia
history of aspiration, poor dentition, foul smelling purulent sputum, infiltrate in dependent lung zone- body position at time of aspiration determine zones of lungs,
Anaerobic PNA Path
Prevotella melanginigenica, peptostreptococcus, fusobacterium, neucleatum, and Bacteroids
Clinical signs of Anaerobic PNA
Constitutional symptoms and cough with expectoration of foul smelling sputum.
Dentition is poor
Imaging- lung abscess & necrotizing pneumonia & empyema
Anaerobic PNA- Treatment
Betalactam/lactamase inhibitor combined with carbapenem or clindamycin. Second line is penicillin and metronidazole and typically for 3 weeks
Thoracic surgery referral for large/non-resolving abscesses
Pulmonary Venous Thromboembolism
VTE- referred to as PE
can be caused by air, amniotic fluid, fat, foreign bodies, parasite eggs, septic emboli, tumor cells,
most common from venous system in the deep veins of lower extremities
Sign & Symptoms of VTE
depend on size and preexisting cardiopulmonary status,
dyspnea and pain (pleuritic chest pain), hemoptysis, syncope, tachy, tachypnea, hypoxia
Lab findings VTE
ECG
ABG
D-dimer
Imaging and special exam for VTE
Chest radiography
Pulmonary CT-angio- GOLD STANDARD
Ventilation-perfusion
Venous thrombosis studies- US
Pulmonary angio
WELL score/ PERC
Treatment for VTE- Anticoagulation
Mainstay for VTE- considered even before a confirmed diagnosis with low risk of bleeding. unfractionated heparin, Direct acting oral anticoagulants- First line
Measure d-dimer a month after stopping treatment, duration of anticoagulation depends on risk factors for recurrence
Pleuritis
pleuritic pain due to inflammation of the parietal pleura pain is localized, sharp and fleeting, made worst by cough, sneezing, deep breathing, and movement,
Causes- VRI, PE, inflammatory disorders, malignancy,
Tx- underlying condition and NSAIDs
Pleural Effusion
abnormal accumulation of fluid in the pleural space: Transudates, exudates, empyema, hemothorax
Transudates
Increased production of fluid in the setting of normal capillaries due to increased hydrostatic or decreased oncotic pressure- HF, Cirrhosis, Nephrotic syndrome, peritoneal dialysis, myxedema, atelectasis, constrictive pericarditis, superior vena cava obstruction, PE
Exudates
increased production of fluid due to abnormal capillary permeability; decreased lymphatic clearance of fluid from the pleural space- PNA, CA, PE, bacterial infection, TB, Infections, asbestos, and more…
Empyema
infection in the pleural space
hemothorax
bleeding in the pleural space
Diagnostic Thoracentesis- Pleural effusion
done when there is a new pleural effusion without cause
S&S of pleural effusion
dyspnea, cough, respirophasic chest pain, physical signs may not be present in small effusion, larger effusion will have dullness, diminished or absent breath sounds, massive effusions will cause trachea shift and bulging in intercostal space
Treatment of pleural effusion
Transudative- Underlying disease
Malignant pleural effusion- no tx or therapeutic tx
Parapneumonic- Uncomplicated- no tx just treat PNA, Complicated- to drain or not drain, Empyema- should be drained
Hemothorax- observation or tube
Pneumothorax
Accumulation of air in pleural space- Spontaneous (primary/secondary), traumatic, iatrogenic, tension
Primary Spontaneous Pneumothorax
occurs in absence of underlying lung disease- tall, thin, men, young age, occur from rupture of sub-pleural apical blebs in response to high negative intrapleural pressure, cigarettes correlated so are connective tissue disease
Secondary Spontaneous Pneumothorax
complication of preexisting pulmonary disease, COPD, interstitial lung disease, asthma, Cystic fibrosis, TB, pneumocystis PNA, and more
Traumatic Pneumothorax
penetrating or blunt trauma and includes iatrogenic caused by a procedure
Tension Pneumothrax
pressure of air in the pleural space exceeds alveolar and venous pressure throughout the respiratory cycle, resulting in compression of lung and reduction of venous return to hemithorax
Clinical S&S Pneuomthorax
Acute unilateral chest pain and dyspnea, cough, if large- diminished brother sounds, decreased tactile fremitus, decreased movement of chest, hyper-resonant percussion note,
Treatment of Pneumothrax
depends on severity, observation vs aspiration of air vs small bore chest tube
Hyperventilation syndrome
increased alveolar minute ventilation leads to hypocapnia can be caused by pregnancy, hypoxemia obstructive and infiltrative lung disease, sepsis, lever dysfunction, fever and pain, can be acute or chronic
Acute hyperventilation
Hyperpnea, anxiety, parenthesis, carpopedal spasm and tetany
Chronic Hyperventilation
nonspecific symptoms- fatigue, dyspnea, anxiety, palpitations and dizziness, dx established only if symptoms are reproduced during voluntary hyperventilation, tx- pursed lips breathing, rebreathing expired gas, anxiolytic drugs can help
Obesity- Hypoventilation Syndrome
Pickwickian Syndrome
result from combination of blunted ventilatory drive and increased mechanical load opposed upon chest due to obesity
tx: weight loss and avoid sedative hypnotic, opioids, alcohol and NIPPV
Obstructive Sleep Apnea in adults
upper airway obstruction during sleep when loss of normal pharyngeal muscles tone allows pharynx to collapse passively during inspiration, Risk factors: anatomically small airways (obesity, tonsillar hypertrophy), alcohol, sedatives, nasal obstruction of any type, hypothyroidism and smoking,
Sleep Apnea S&S
Middle age men, excessive daytime fatigue, cognitive impairment and recent weight gain and impotence, loud cyclical snoring, breathing cessation, restlessness, thrashing movements,
Studies for dx of Sleep Apnea
polysomnography
otorhinolaryngologic exam
RSV- Respiratory syncytial virus
paramyxovirus that has annual outbreaks in the winer
Major cause of morbidity and mortality at extreme ages and no vaccination is available
Bronchiolitis, proliferation and necrosis of bronchiolar epithelium causing obstruction from sloughed epithelium and increased mucus secretion
RSV Risk factors
Prematurity & bronchopulmonary dysplasia
comorbid conditions
immunocompromised
S&S of RSV
signs of infection- low grade fever, tachypnea, wheezes
Apnea
hyper-inflated lungs, decreased gas exchange, and increased work of breathing
Pulmonary hemorrhage is reported
Lab Findings for RSV
Rapid dx is done by viral antigen identification of nasal washing using ELISA or immunofluorescent assays; PCR rapid test
Treatment of RSV
supportive care; hydration, humidification, abx if PNA is present,
HIGH RISK- treatments are available in hospital
Human Metapneumovirus
Paramyxoviruses
Late winter- early spring
presents as mild upper to severe lower respiratory tract infection
Lower respiratory tract infection seen among immunocompromised and elderly- nursing homes
PCR dx this
Human Parainfluenza viruses- HPIVS
Paramyxovirus, commonly seen in children and cause of croup (HPIV-1 and 2). HPIV-3 bronchiolitis and PNA, type 4 is rare.
Can cause serve disease in elderly, immunocompromised and chronic illness
PCR, ELISA and immunofluorescence are used for detection
Nipah Virus
Paramyxoviruses
Mostly in south Asia- fruit bats are host
causes acute encephalitis with high fatality rate
respiratory symptoms are present but more neuro
Dx with ELISA and PCR
Seasonal Influenza
highly contagious disease transmitted by droplet
three types A-C
S&S of Flu
Incubation is 1-4 days
fever, chills, headache, malaise, myalgia, rhinorrhea, congestion, pharyngitis, hoarseness, nonproductive cough, substernal soreness
Fever can last 1-7 days
Elderly can present with confusion, without fever or respiratory symptoms
Lab findings of FLU
rapid influenza from nose or throat swabs
empirically treatment is recommended even without testing
Complications of influenza
Hospitalization due to viral pneumonitis and severe hypoxemia- high risk for 65 and older, obese and chronic conditions
Pregnant people at high risk
necrosis of respiratory epithelium and can cause bacterial PNA
MI, CVA, sudden death,
Reye Syndrom
Treatment of Influenza
Supportive
Antiviral- recommenced to start at 48 hours of illness
*oseltamivir- 75mg BID x 5 days
*Inhaled Zanamivir
*Baloxavir
Prognosis of Influenza
duration is 1-7 days of uncomplicated illness
Fatalities are related to bacterial PNA
Prevention of Influenza
Annual administration of influenza vaccine
Avian influenza
Birds are natural host
indistinguishable from seasonal influenza
Risk factors for Avian Flu
direct or indirect exposure to infected live or dead poultry or contaminated environments
Clinical Signs and Symptoms of Avian FLU
Similar to influenza
fever with lower respiratory symptoms, gastrointestinal symptoms with H5N1
conjunctivitis with H7
Lab findings for Avian Flu
commercial rapid antigen test are not sensitive to detect and should not be used ti be definitive test, RT-PCR assays are available through hospitals and state health department,
Positive test must be forwarded to state health departments
Treatment of Avian Flu
Treatment as soon as possible
Antivirals
*oseltamivir
Prevention of Avian Flu
avoidance of exposure
Adenovirus Infections
60 serotypes
self-limited and clinically inapparent
morbidity and mortality in immunocompromised
S&S of adenovirus
incubation 4-9 days
rhinitis, pharyngitis, mild malaise without fever, conjunctivitis, non streptococcal exudative pharyngitis with fever for 2-12 days, and lower respiratory infection may occur
specific adenoviruses have specific symptoms
Lab Findings of adenovirus
antigen detection with direct fluorescence assay or enzyme immunoassay are rapid
PCR is required for negative assay
CT/xray- multifocal consolidation or ground glassy opacity without airway inflammatory findings